stockrowElevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
Follow ELV
Alert me
Elevance Health, Inc. (ELV) EBITDA
Elevance Health, Inc.'s EBITDA for fiscal 2025 was $9.7B, down 7.86% from $10.5B in fiscal 2024. Over the twelve months to 30 September 2026 it was $9.2B. Over the past ten years it has ranged from $5.9B (fiscal 2017) to $10.5B (fiscal 2023); the current reading is higher than 64% of that period. Elevance Health, Inc. ranks 4th of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $9.7B | (7.86%) |
| FY2024 | $10.5B | (0.08%) |
| FY2023 | $10.5B | 3.59% |
| FY2022 | $10.1B | 0.10% |
| FY2021 | $10.1B | 23.19% |
| FY2020 | $8.2B | 4.40% |
| FY2019 | $7.9B | 12.95% |
| FY2018 | $7.0B | 18.52% |
| FY2017 | $5.9B | (5.07%) |
| FY2016 | $6.2B | 0.12% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $2.5B | (5.70%) |
| Jun 2026 | $2.7B | (11.54%) |
| Mar 2026 | $3.0B | 205.47% |
| Dec 2025 | $987.0M | (53.96%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $28.2B |
| CVS CVS Health Corporation compare | $19.6B |
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. | $9.2B |
| HUM Humana Inc. compare | $3.1B |
| CNC Centene Corporation compare | $2.2B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $333.0M |
| PGNY Progyny, Inc. compare | $117.9M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on ELV
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement